Edition:
United Kingdom

Fennec Pharmaceuticals Inc (FENC.OQ)

FENC.OQ on NASDAQ Stock Exchange Capital Market

7.47USD
19 Oct 2018
Change (% chg)

$-0.12 (-1.58%)
Prev Close
$7.59
Open
$7.60
Day's High
$7.71
Day's Low
$7.47
Volume
8,672
Avg. Vol
29,599
52-wk High
$14.85
52-wk Low
$7.20

Chart for

About

Fennec Pharmaceuticals Inc., formerly Adherex Technologies Inc., is a biopharmaceutical company focused on cancer therapeutics. The Company's lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the... (more)
No analyst recommendations are available for .

Overall

Beta: -0.92
Market Cap(Mil.): $234.13
Shares Outstanding(Mil.): 15.86
Dividend: --
Yield (%): --

Financials

  FENC.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -0.37 -- --
ROI: -56.50 0.21 14.27
ROE: -56.50 1.17 15.99

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $139.05 -0.45
Roche Holding Ltd. (ROG.S) CHF244.95 +6.40
Roche Holding Ltd. (RO.S) CHF245.20 +5.80
Pfizer Inc. (PFE.N) $44.50 +0.50
Novartis AG (NOVN.S) CHF87.04 +1.16
Sanofi SA (SASY.PA) €77.80 0.00
Abbott Laboratories (ABT.N) $67.59 -0.55
Merck & Co., Inc. (MRK.N) $72.35 +0.14
AstraZeneca plc (AZN.L) 5,934.00 +56.00
Amgen, Inc. (AMGN.OQ) $201.80 -0.92

Earnings vs. Estimates

No consensus analysis data available.